Gynesonics
604 Fifth Avenue
Suite D
Redwood City
California
94063
United States
Tel: 650-216-3860
Fax: 650-299-1566
Website: http://www.gynesonics.com/
Email: info@gynesonics.com
53 articles about Gynesonics
-
Gynesonics Announces Another Peer-Reviewed Publication And Presentation Of Significant International Clinical Experience With VizAblate Technology For Symptomatic Uterine Fibroids
12/9/2014
-
Gynesonics Receives FDA Approval To Commence A Pivotal IDE Clinical Trial For The Newly-Designed Vizablate® System
10/22/2014
-
Gynesonics Names Richard P. Lanigan Vice President, Global Commercialization
8/7/2014
-
Gynesonics Adds $6 Million For Fibroid Device
7/10/2014
-
Gynesonics Announces First Patient Successfully Treated With Newly Designed Incisionless VizAblate® System For Symptomatic Uterine Fibroids
6/24/2014
-
Gynesonics Receives CE Mark on Next Generation VizAblate® System for the Treatment of Symptomatic Uterine Fibroids
6/12/2014
-
Gynesonics Taps A New Chief Executive Officer
4/22/2014
-
Gynesonics Completes $21 Million Series D Financing
2/20/2013
-
Gynesonics Raises $5 Million in Funding
2/22/2012
-
Gynesonics Announces the Start of the FAST-EU Study for the VizAblate(R) System
9/22/2011
-
Gynesonics Receives the CE-Mark for the VizAblateTM System to Treat Uterine Fibroids
1/6/2011
-
Industry Veteran Karen Talmadge Joins Gynesonics Board of Directors
6/6/2007
-
Gynesonics Completes $16.5 Million Series B Financing
1/24/2007